What drove SenesTech's record first-half 2024 revenue, and how did Q2 revenue perform year-over-year?

SenesTech's record first-half 2024 revenue was driven by its Evolve product line; specifically, Q2 revenue increased 50% year-over-year.

What is the current regulatory and commercial status of SenesTech's Evolve and Evolve Mouse products?

SenesTech's Evolve and Evolve Mouse products—fertility control solutions for rodents—are gaining widespread state approvals and expanding distribution.

SenesTech (SNES) Q2 2024 Earnings Summary

Jun 19, 2026

SenesTech reported record H1 2024 revenue driven by its Evolve rodent fertility control products, with Q2 revenue up 50% year-over-year. Management anticipates accelerated growth but notes additional capital is needed for sustained profitability.

Quartr

2026-06-19

SenesTech (SNES) Q2 2024 Earnings Summary

2026-07-30

SenesTech to Report Second Quarter 2026 Financial Results on Wednesday, August 5, 2026

2026-08-04

SenesTech Inc (SNES) Q2 2026 Earnings Preview: GF Value Indicates 74% Downside

2026-08-05

SenesTech Reports Record Q2 2026 Revenue and Gross Margin as E-commerce Growth Accelerates

2026-08-05

SenesTech Q2 2026 Earnings: E-commerce Lifts Revenue and Gross Margin